BEIJING,Aug. 27,2024--Shanghai Ark Biopharmaceutical Co.,Ltd. ("ArkBio"),a privately held,clinical-stage biopharmaceutical company today announced that Dr. Jim Wu,Chief Executive Officer of
The online investment business has agreed to be acquired by CVC Capital Partners, Nordic Capital and Platinum Ivy, a subsidiary of sovereign wealth fund the Abu Dhabi Investment Authority.